Ambulatory blood pressure monitoring-derived short-term blood pressure variability in primary hyperparathyroidism

被引:14
作者
Concistre, A. [1 ]
Grillo, A. [2 ]
La Torre, G. [1 ]
Carretta, R. [3 ]
Fabris, B. [3 ]
Petramala, L. [1 ]
Marinelli, C. [1 ]
Rebellato, A. [4 ]
Fallo, F. [4 ]
Letizia, C. [1 ]
机构
[1] Univ Roma La Sapienza, Dept Internal Med & Med Specialties, Rome, Italy
[2] Univ Milano Bicocca, Dept Med & Surg, Milan, Italy
[3] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy
[4] Univ Padua, Dept Med DIMED, Padua, Italy
关键词
Short-term blood pressure variability; Hypertension; Primary hyperparathyroidism; ABPM; PARATHYROID-HORMONE; PROGNOSTIC-SIGNIFICANCE; VITAMIN-D; HYPERTENSION; DYSFUNCTION; RISK; REACTIVITY; STIFFNESS; DISEASE; SURGERY;
D O I
10.1007/s12020-017-1362-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Primary hyperparathyroidism is associated with a cluster of cardiovascular manifestations, including hypertension, leading to increased cardiovascular risk. The aim of our study was to investigate the ambulatory blood pressure monitoring-derived short-term blood pressure variability in patients with primary hyperparathyroidism, in comparison with patients with essential hypertension and normotensive controls. Twenty-five patients with primary hyperparathyroidism (7 normotensive,18 hypertensive) underwent ambulatory blood pressure monitoring at diagnosis, and fifteen out of them were re-evaluated after parathyroidectomy. Short-term-blood pressure variability was derived from ambulatory blood pressure monitoring and calculated as the following: 1) Standard Deviation of 24-h, day-time and night-time-BP; 2) the average of day-time and night-time-Standard Deviation, weighted for the duration of the day and night periods (24-h "weighted" Standard Deviation of BP); 3) average real variability, i.e., the average of the absolute differences between all consecutive BP measurements. Baseline data of normotensive and essential hypertension patients were matched for age, sex, BMI and 24-h ambulatory blood pressure monitoring values with normotensive and hypertensive-primary hyperparathyroidism patients, respectively. Normotensive-primary hyperparathyroidism patients showed a 24-h weighted Standard Deviation (P < 0.01) and average real variability (P < 0.05) of systolic blood pressure higher than that of 12 normotensive controls. 24-h average real variability of systolic BP, as well as serum calcium and parathyroid hormone levels, were reduced in operated patients (P < 0.001). A positive correlation of serum calcium and parathyroid hormone with 24-h-average real variability of systolic BP was observed in the entire primary hyperparathyroidism patients group (P = 0.04, P = 0.02; respectively). Systolic blood pressure variability is increased in normotensive patients with primary hyperparathyroidism and is reduced by parathyroidectomy, and may potentially represent an additional cardiovascular risk factor in this disease.
引用
收藏
页码:129 / 137
页数:9
相关论文
共 40 条
  • [1] Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: Dependent or independent risk factors?
    Anderson, Jeffrey L.
    Vanwoerkom, Ryan C.
    Horne, Benjamin D.
    Bair, Tami L.
    May, Heidi T.
    Lappe, Donald L.
    Muhlestein, Joseph B.
    [J]. AMERICAN HEART JOURNAL, 2011, 162 (02) : 331 - U162
  • [2] Primary hyperparathyroidism and heart disease - a review
    Andersson, P
    Rydberg, E
    Willenheimer, R
    [J]. EUROPEAN HEART JOURNAL, 2004, 25 (20) : 1776 - 1787
  • [3] Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Fourth International Workshop
    Bilezikian, John P.
    Brandi, Maria Luisa
    Eastell, Richard
    Silverberg, Shonni J.
    Udelsman, Robert
    Marcocci, Claudio
    Potts, John T., Jr.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (10) : 3561 - 3569
  • [4] A new method for assessing 24-h blood pressure variability after excluding the contribution of nocturnal blood pressure fall
    Bilo, Grzegorz
    Giglio, Alessia
    Styczkiewicz, Katarzyna
    Caldara, Gianluca
    Maronati, Alberto
    Kawecka-Jaszcz, Kalina
    Mancia, Giuseppe
    Parati, Gianfranco
    [J]. JOURNAL OF HYPERTENSION, 2007, 25 (10) : 2058 - 2066
  • [5] Current evidence for recommendation of surgery, medical treatment and vitamin D repletion in mild primary hyperparathyroidism
    Bollerslev, Jens
    Marcocci, Claudio
    Sosa, Manuel
    Nordenstrom, Jorgen
    Bouillon, Roger
    Mosekilde, Leif
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2011, 165 (06) : 851 - 864
  • [6] PTH: A New Target in Arteriosclerosis?
    Buizert, Petra J.
    van Schoor, Natasja M.
    Simsek, Suat
    Lips, Paul
    Heijboer, A. C.
    den Heijer, M.
    Deeg, Dorly J. H.
    Eekhoff, Elisabeth M. W.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (10) : E1583 - E1590
  • [7] PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE
    COCKCROFT, DW
    GAULT, MH
    [J]. NEPHRON, 1976, 16 (01) : 31 - 41
  • [8] Parathyroidectomy erase increased myocardial electrical vulnerability in patients with primary hyperparathyroidism
    Curione, M.
    Amato, S.
    Di Bona, S.
    Petramala, L.
    Cotesta, D.
    Letizia, C.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 141 (02) : 201 - 202
  • [9] de la Torre NG, 2003, ENDOCR-RELAT CANCER, V10, P309
  • [10] Diagnosis of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Fourth International Workshop
    Eastell, Richard
    Brandi, Maria Luisa
    Costa, Aline G.
    D'Amour, Pierre
    Shoback, Dolores M.
    Thakker, Rajesh V.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (10) : 3570 - 3579